Clinical Trials Update: May 16, 2006
Diabetes - Type 2 Asthma (Pediatric) High Cholesterol (Hyperlipidemia)
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Diabetes - Type 2
This year long, six-visit study will evaluate the safety and effectiveness of a research medication for type 2 diabetes. To qualify, you must be 18 or older and taking insulin and no oral diabetic medication. If you participate, you will receive diabetic counseling, physical exams, and study medications.
The research site is in Nashville, Tenn.
This research study will compare the investigational use of a marketed medication to treat children with asthma and seasonal allergies. Your child may qualify if he or she is 6-14, has been diagnosed with asthma, and has asthma symptoms during allergy season. The 7-week study will include four office visits and one telephone assessment. Qualified participants will receive all study-related medical care and the study drug or inactive placebo at no cost.
The research site is in Munfordville, Ky.
High Cholesterol (Hyperlipidemia)
This 5-year study will evaluate the approved drug Crestor as a treatment to prevent cardiovascular disease. To qualify, you must be taking Crestor and be a male over age 50 or a female over age 60, with no history of diabetes, cancer, or prior cardiovascular event such as heart attack, angina, or stroke. Additional criteria apply. Patients will receive free study-related evaluations and medications, and will be compensated for their time.
The research site is in Indianapolis, Ind.
Copyright 2006 CenterWatch. All rights reserved.